- Home
- NMRK vs BHC Comparison
NMRK vs BHC Comparison
Compare NMRK & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRK
- BHC
- Stock Information
- Founded
- NMRK 1929
- BHC N/A
- Country
- NMRK United States
- BHC Canada
- Employees
- NMRK N/A
- BHC N/A
- Industry
- NMRK Real Estate
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- NMRK Finance
- BHC Health Care
- Exchange
- NMRK Nasdaq
- BHC Nasdaq
- Market Cap
- NMRK 2.0B
- BHC 2.0B
- IPO Year
- NMRK 2017
- BHC N/A
- Fundamental
- Price
- NMRK $11.22
- BHC $4.59
- Analyst Decision
- NMRK Buy
- BHC Hold
- Analyst Count
- NMRK 4
- BHC 5
- Target Price
- NMRK $15.67
- BHC $7.20
- AVG Volume (30 Days)
- NMRK 1.1M
- BHC 2.6M
- Earning Date
- NMRK 04-30-2025
- BHC 04-30-2025
- Dividend Yield
- NMRK 1.06%
- BHC N/A
- EPS Growth
- NMRK 81.01
- BHC N/A
- EPS
- NMRK 0.38
- BHC N/A
- Revenue
- NMRK $2,857,497,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- NMRK $11.92
- BHC $4.92
- Revenue Next Year
- NMRK $9.07
- BHC $2.36
- P/E Ratio
- NMRK $29.94
- BHC N/A
- Revenue Growth
- NMRK 14.48
- BHC 8.53
- 52 Week Low
- NMRK $9.64
- BHC $3.96
- 52 Week High
- NMRK $16.10
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- NMRK 50.15
- BHC 34.85
- Support Level
- NMRK $10.70
- BHC $4.63
- Resistance Level
- NMRK $11.47
- BHC $4.86
- Average True Range (ATR)
- NMRK 0.39
- BHC 0.25
- MACD
- NMRK 0.13
- BHC -0.00
- Stochastic Oscillator
- NMRK 80.62
- BHC 6.02
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.